InfuSystem Holdings, Inc (INFU)

↓ Download CSV

CIK 0001337013 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, InfuSystem Holdings, Inc reported revenue of $143.44M, up 6.4% from the prior year. The company was profitable, with a net margin of 4.6% and a gross margin of 56.0%. It held $100.56M in total assets against $43.23M in total liabilities.

Key ratios (FY2025)

56.0%
Gross margin
8.3%
Operating margin
4.6%
Net margin
11.6%
Return on equity
+6.4%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$143.44M$134.86M$125.78M$109.91M$102.38M$97.39M$81.11M$67.14M$71.08M
Cost of Revenue$63.14M$64.46M$62.68M$49.35M$43.85M$38.63M$34.23M$27.57M$18.37M$16.21M
Gross Profit$80.30M$70.40M$63.11M$60.56M$58.54M$58.76M$46.88M$39.57M$43.36M$44.74M
Operating Income$11.92M$6.89M$4.09M$1.65M$2.82M$8.83M$3.52M$415.0K-$3.81M$974.0K
Net Income$6.63M$2.35M$872.0K$18.0K$1.42M$17.33M$1.36M-$1.09M-$20.71M-$222.0K
EPS (Diluted)$0.31$0.11$0.04$0.00$0.06$0.80$0.07$-0.05$-0.91$-0.01
Total Assets$100.56M$103.61M$102.92M$99.39M$97.59M$96.99M$79.22M$64.07M$68.88M$96.34M
Total Liabilities$43.23M$46.09M$50.61M$51.38M$49.31M$56.24M$56.89M$43.63M$37.93M$45.66M
Shareholders' Equity$57.33M$57.53M$52.30M$48.00M$48.27M$40.75M$22.33M$20.44M$30.95M$50.69M
Cash & Equivalents$3.19M$527.0K$231.0K$165.0K$186.0K$9.65M$2.65M$4.32M$3.47M$3.40M
Operating Cash Flow$24.41M$20.46M$11.22M$17.52M$18.32M$20.28M$13.88M$11.39M$7.72M$7.91M
Capital Expenditures$560.0K$1.09M$1.02M$982.0K$980.0K$1.09M$2.93M$281.0K$104.0K$168.0K
Shares Outstanding21.10M21.71M21.65M21.55M22.05M21.72M20.84M21.42M22.74M22.62M